# Stereotactic Radiotherapy (SRT) Liver (COLD 1)

> **NCT00152906** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 140 (estimated)

## Conditions studied

- Liver Neoplasms
- Neoplasm Metastases

## Interventions

- **PROCEDURE:** Stereotactic radiotherapy (SRT) or highly conformal (CRT)

## Key facts

- **NCT ID:** NCT00152906
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2016-07
- **Final completion:** 2020-07-10
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152906, "Stereotactic Radiotherapy (SRT) Liver (COLD 1)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00152906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*